sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Patient Information Leaflet last updated on the eMC: 25/02/2011
PIL Ikorel Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 25/02/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about overdose
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to dosage and administration
Updated on 20/04/2009 and displayed until 25/02/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
Updated on 02/01/2009 and displayed until 20/04/2009
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 06/08/2008 and displayed until 02/01/2009
Reasons for adding or updating:
  • Change to manufacturer contact details
  • Change due to user-testing of patient information
Updated on 20/09/2007 and displayed until 06/08/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 26/11/2004 and displayed until 20/09/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 01/07/2004 and displayed until 26/11/2004
Reasons for adding or updating:
  • Change to drug interactions
Updated on 30/08/2000 and displayed until 01/07/2004
Reasons for adding or updating:
  • No reasons supplied
Updated on 09/08/2000 and displayed until 30/08/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   nicorandil